The Citizens Charter for the Electronic Drug Price Monitoring System contains several steps and processes focused on certification and registration. To learn more about the Charter, please click on the link.
Removal of Metronidazole and Glibenclamide Preparations in the Government-Mediated Access Price (GMAP) List
The Department of Health has removed certain medicines from the Government-Mediated Access Price (GMAP) list. For more details on these changes, you can access the full information of the circular here.
Advisory for the Public Consultation on the Draft Administrative Order entitled “Revised Implementing Guidelines on the Electronic Drug Price Monitoring System”
Republic Act No. 9502, otherwise known as the “Universally Accessible Cheaper and Quality Medicines Act of 2008,” mandated the Secretary of Health (SOH)to establish and initiate an electronic price monitoring and regulation system for drugs and medicines which is now known as the Electronic Drug Price Monitoring System (EDPMS).
Click the title to read more about the advisory.
Advisory on the adjustments in the price of the medicines under GMAP
The department of health have adjusted the price of several medicines under Government-Mediated Access Price (GMAP). To know more regarding the changes you can access the full contents here.
DOH updates list of VAT-Exempt Medicines under RA 11354
The Department of Health (DOH) informed the Bureau of Internal Revenue (BIR) through Commissioner Caesar R. Dulay the revisions to the list of VAT-Exempt Medicines under Republic Act. 11354 or Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.
Duterte Legacy Summit highlights DOH efforts on setting Maximum Retail Price for high-cost medicines
The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.
Signed Endorsement Letters for the Updated List of Vat-Exempt Medicines Under Republic Act 11534 known as Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act
The Food and Drug Administration (FDA) endorses to the Bureau of Internal Revenue (BIR) the updated list of VAT-Exempt Medicines (as of March 2022) under RA 11354, otherwise known as the Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.
DOH Lauds New Price Caps on Medicines
The Department of Health expressed elation over the signing of Executive Order (EO) No. 155, by President Rodrigo Roa Duterte adding 34 medicines to the list of drugs with mandatory price caps.
Adjustments in Maximum Retail Price (MRP) Regulation of Certain Medicines that are Covered by Executive Order No. 155 Pursuant to Exemption from Value Added Tax (VAT)
DOH informs the public of the adjustments in the Maximum Retail Price (MRP) of certain medicines that are covered by EO 155
(Department Circular No. 2022-0046) Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations
Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations Related Posts Maximum Retail Price of Drugs and Medicines 14 Sep 2020 (Executive Order #155) Further Improving Access to Healthcare continue reading : (Department Circular No. 2022-0046) Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations